SENTI BIO
Live / Registered — Registered (as of 08 Oct 2024)
What this means for you
Registered since 08 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88589875
- Registration number
- 7530747
- Mark type
- Stylized text
- Filed
- 23 Aug 2019
- Published for opposition
- 21 Jul 2020
- Registered
- 08 Oct 2024
- Attorney of record
- Nicole Kinsley, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; genetic material for medical or clinical use; house mark for prescription pharmaceutical products for human use for treating diseases through cell therapy or gene therapy
Owner
- Senti Biosciences, Inc., South San Francisco, CA, US
- Senti Biosciences, Inc., South San Francisco, CA, US
- Senti Biosciences, Inc., South San Francisco, CA, US
Prosecution history
- 08 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Sept 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Sept 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jun 2024 — USE AMENDMENT FILED
- 12 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jun 2024 — TEAS STATEMENT OF USE RECEIVED
- 27 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Mar 2024 — SOU EXTENSION 5 GRANTED
- 26 Mar 2024 — SOU EXTENSION 5 FILED
- 26 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 14 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2023 — SOU EXTENSION 4 GRANTED
- 12 Sept 2023 — SOU EXTENSION 4 FILED